Interstitial Lung Disease Research
NYU Langone’s Division of Pulmonary, Critical Care, and Sleep Medicine conducts multidisciplinary research on interstitial lung diseases to improve the diagnosis and advance patient care of these complex conditions.
Rany Condos, MD, leads our multidisciplinary interstitial lung disease research program. The study and treatment of these conditions require the expertise of not only pulmonologists, but also a group of other disciplines, including critical care specialists, radiologists, and pathologists.
Our research in advanced interstitial lung diseases is focused on expanding available information, therapies, and regional networks to improve the diagnosis of these disorders.
We are also developing clinical trials to prevent progression and induce regression of lung fibrosis resulting from COVID-19–related acute lung injury and acute respiratory distress syndrome, funded by the National Institute of Allergy and Infectious Diseases.
Wang J … Segal LN. Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ. ERG Open Res. 2017. DOI.